VaramirStart free · no cardSign in

NKTR relationship map

NKTR

Nektar Therapeutics

Overview

Supply chain

SEC EDGAR · Mar 13 '26
Sources
KRC
1.60% of KRC ABR10-K
2°Splunkunlisted
2°NBIX
2°BOX
BMY
2°CTMX
2°VNDA
2°PRTA
Gannet BioChemunlisted
← Buys from
NKTR
UCBunlisted
39.00% of NKTR rev10-K
Baxalta (a subsidiary of Takeda Pharmaceutical Company Limited)unlisted
18.00% of NKTR rev10-K
AZN
17.00% of NKTR rev10-K
2°IRWD
2°MNPR
2°ADCT
PFE
12.00% of NKTR rev10-K
2°CRBU
2°PLX
2°OLMA
Rocheunlisted
10.00% of NKTR rev10-K
BMY
2°CTMX
2°VNDA
2°PRTA
LLY
2°IMRX
2°UTHR
2°CNDA
Gannet BioChemunlisted
Healthcare Royalty Management, LLC (HCR)unlisted
RPI Finance Trust (RPI)unlisted
TrialNetunlisted
Sells to →
Suppliers3Customers11
KRC1.60% ABR10-K
BMY
Gannet BioChemunlisted
NKTR
UCBunlisted39.00% of NKTR rev10-K
Baxalta (a subsidiary of Takeda Pharmaceutical Company Limited)unlisted18.00% of NKTR rev10-K
AZN17.00% of NKTR rev10-K
PFE12.00% of NKTR rev10-K
Rocheunlisted10.00% of NKTR rev10-K
BMY
LLY
Gannet BioChemunlisted
+3 more
suppliercustomerunlisted2°second-degree (Extended)
Thick line = filed share ·Moves · 00:40 ETSources